# FDA Inspection 834018 - SpecGx LLC - May 24, 2013

Source: https://www.keypedia.com/records/fda_inspections/specgx-llc/3cfd1ffd-8673-4de0-a3ad-1f2293474b09
Source feed: FDA_Inspections

> FDA Inspection 834018 for SpecGx LLC on May 24, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 834018
- Company Name: SpecGx LLC
- Inspection Date: 2013-05-24
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1283454 - 2025-10-22](https://www.keypedia.com/records/fda_inspections/specgx-llc/24ece6fd-a035-4331-89ab-8ddb59db42f9)
- [FDA Inspection 1283454 - 2025-10-22](https://www.keypedia.com/records/fda_inspections/specgx-llc/4ef58d63-e23f-4c06-9834-380b593fbb90)
- [FDA Inspection 1283454 - 2025-10-22](https://www.keypedia.com/records/fda_inspections/specgx-llc/cbc1b2fb-753f-4dd6-aa20-30ef2fbc7c06)
- [FDA Inspection 1283454 - 2025-10-22](https://www.keypedia.com/records/fda_inspections/specgx-llc/4554a61d-9334-4f7c-8b16-11f2c2cbfe6a)
- [FDA Inspection 1163660 - 2022-02-11](https://www.keypedia.com/records/fda_inspections/specgx-llc/42e52827-265a-4039-8bff-a00d227c7ee8)

Company: https://www.keypedia.com/companies/specgx-llc/a659fe71-9183-4c7c-96ca-9214c6a9c177

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c